European Commission Approves Lone Neuroblastoma Immunotherapy – Rare Disease Report
Rare Disease Report |
European Commission Approves Lone Neuroblastoma Immunotherapy
Rare Disease Report The announcement makes dinutuximab beta the only immunotherapy for the disorder approved in Europe. An estimated 1,200 children in Europe are diagnosed with neuroblastoma annually, and because the cancer can spread so quickly, almost half of that … Cancer drug to treat deadly neuroblastoma can be prescribed on NHS – new hope for children |
